Research-informed explainer · Last reviewed April 12, 2026
Pelvic Organ Prolapse: Surgery vs Pessary — What to Expect
Pelvic organ prolapse can be treated with surgery or a pessary. Both work, but suit different patients. Here is what the clinical evidence says about each option.
Research-informed explainer — last updated April 12, 2026
Pelvic organ prolapse surgery and pessary treatment are both effective options — neither is universally better. Surgery aims for a long-term structural repair, while a pessary is a non-surgical device that supports prolapsed tissue and relieves symptoms as long as it is in place. Most women who want to avoid surgery can successfully use a pessary, and most women who want a permanent repair can get one. The decision is driven by your goals, your prolapse severity, your health, and whether you want to preserve fertility.
This explainer draws on clinical research from three specialists in female pelvic medicine and urogynecology in the Convene directory. Howard Goldman at Cleveland Clinic co-authored the 6th International Consultation on Incontinence recommendations and multiple ICS/IUGA terminology and guideline documents that define the clinical standards for evaluating and treating prolapse. Victor Nitti at UCLA contributed to the foundational Fourth International Consultation on Incontinence report and published definitive trials on overactive bladder management, a condition that frequently accompanies prolapse. Sandip Vasavada at Cleveland Clinic co-authored both the 2015 and 2019 AUA/SUFU guidelines on overactive bladder, which address the pelvic floor conditions that overlap substantially with prolapse.
What is pelvic organ prolapse?
Pelvic organ prolapse (POP) occurs when the pelvic floor muscles and connective tissue weaken, allowing one or more pelvic organs — the bladder (cystocele), uterus, rectum (rectocele), or vaginal vault after hysterectomy — to descend into or beyond the vaginal canal. The IUGA/ICS joint terminology report co-authored by Howard Goldman establishes that prolapse is staged by the degree of descent: Stage I is mild descent above the vaginal opening, Stage II is at or near the opening, and Stages III-IV involve significant protrusion beyond it [3].
Prolapse is common — lifetime surgical risk for prolapse or incontinence is approximately 11% — and its prevalence increases with age, vaginal delivery history, prior pelvic surgery, and obesity. Many women have anatomic prolapse without bothersome symptoms and need no treatment. The trigger for treatment is typically symptoms: pelvic pressure or heaviness, a sensation of bulging, difficulty with urination or bowel movements, or impact on sexual function.
What's the difference?
A pessary is a silicone device inserted into the vagina to mechanically support the prolapsed tissue. It does not repair the underlying defect — it holds the prolapsed organ in place as long as it is positioned correctly. Pessaries come in multiple shapes (ring, Gellhorn, cube, donut, and others), and finding the right fit typically requires a fitting appointment with a gynecologist or urogynecologist. Once fitted, most patients can remove, clean, and reinsert their pessary independently, though some older patients prefer in-office care every three to four months.
Surgical repair aims to restore the native anatomy permanently by reinforcing the weakened pelvic floor support. The specific operation depends on which organs have prolapsed. Common procedures include anterior and posterior colporrhaphy (native tissue repair), sacrocolpopexy (laparoscopic or robotic mesh attachment of the vaginal apex to the sacrum), uterosacral ligament suspension, and sacrospinous fixation. For women who no longer want uterine preservation, hysterectomy may be performed at the same time as vault suspension.
Surgery can be done vaginally, laparoscopically, robotically, or through open abdominal approaches depending on the type of prolapse and surgeon expertise. Recovery ranges from two to six weeks depending on approach.
At a glance
Who is a good candidate for a pessary?
Pessaries are appropriate for women who want to avoid surgery, women who are medically unfit for surgery, and women who are still deciding whether surgery is right for them. Many providers offer a pessary trial even to patients who are planning surgery eventually — it allows the patient to experience symptom relief while making a more deliberate decision.
Most women can be successfully fitted for a pessary. Successful fitting rates in clinical practice range from 60% to 85%. Women who have had a prior hysterectomy, those with very advanced prolapse (Stage III-IV), and those with a short or narrow vagina may have more difficulty achieving a comfortable fit.
Continuation rates are reasonably high. Studies find that approximately 75% of women continue pessary use at two years, primarily because symptom relief is satisfactory and device management becomes routine. The most common reasons for stopping are: discomfort, inability to self-manage, development of discharge or erosion, and preference for definitive surgical treatment.
Pessaries do not treat the prolapse itself — they manage the symptoms. If a woman stops using her pessary, the prolapse and symptoms return. This is not a failure of the pessary; it reflects the nature of conservative management. Some women use a pessary indefinitely and are fully satisfied with that outcome.
Who is a good candidate for surgery?
Surgery is the most appropriate choice when a woman wants a long-term structural repair, when pessary use has failed or is not feasible, or when the prolapse is severe enough that conservative management is unlikely to provide adequate relief.
Age and general health are major factors. Women who are young and otherwise healthy typically tolerate prolapse surgery well and have decades ahead to benefit from a repair. Older women with significant medical comorbidities face higher perioperative risk, and a pessary may be a safer long-term option.
Coexisting stress urinary incontinence is a common reason to choose surgery over pessary management. The 6th International Consultation on Incontinence recommendations co-authored by Howard Goldman address the overlap between prolapse and incontinence explicitly [1]. When prolapse is corrected — either by surgery or by a well-positioned pessary — previously hidden (occult) stress incontinence can emerge because the kinking effect of the prolapsed bladder neck is relieved. Women considering surgery for prolapse should be evaluated for stress incontinence before the operation, and concurrent anti-incontinence surgery (such as a midurethral sling) may be offered at the same time. The AUA/SUFU guideline on surgical treatment of female stress urinary incontinence, co-authored by Howard Goldman, provides the clinical framework for this decision [4].
Surgical success and recurrence
Surgery for pelvic organ prolapse generally produces high initial success rates — most large studies report anatomic success rates of 85% to 95% in the treated compartment at one year. However, prolapse can recur over time, and the recurrence rate depends on which repair was performed, the compartment involved, and whether the patient continues to experience the risk factors (obesity, heavy lifting, chronic cough) that caused the prolapse originally.
Long-term data on surgical recurrence are sobering: up to 30% of women who undergo prolapse surgery will require a repeat procedure within 10 to 15 years. This recurrence rate is one reason that many urogynecologists present pessary as a meaningful alternative even for younger, otherwise healthy women. Choosing surgery does not necessarily mean choosing a permanent solution — it may mean choosing the first of several repairs over a lifetime.
Native tissue repairs (without mesh) are now preferred for vaginal procedures following FDA concerns about transvaginal mesh in the 2010s. Abdominal and laparoscopic sacrocolpopexy still uses mesh and has strong long-term data, but is a more involved procedure. Your surgeon's experience with specific techniques matters considerably for outcomes.
Overactive bladder and prolapse: the connection
Prolapse and overactive bladder (urgency incontinence, urinary frequency, urgency) commonly coexist, and treatment of one may improve or worsen the other. Research from Sandip Vasavada and colleagues, published in the AUA/SUFU overactive bladder guideline updates, addresses the management of the bladder symptoms that frequently accompany pelvic floor dysfunction [8, 9]. When prolapse is corrected — by pessary or surgery — the distorted anatomy that contributes to bladder outlet obstruction or bladder overdistension may resolve, and overactive bladder symptoms may improve.
However, prolapse repair does not always resolve overactive bladder. Women with longstanding urgency symptoms should understand that surgery for the prolapse is not guaranteed to cure bladder symptoms. In some cases, a pessary trial before surgery gives useful information about which symptoms are prolapse-driven (and likely to improve) versus those that are bladder-intrinsic and will need separate treatment.
Victor Nitti's foundational work on overactive bladder pharmacotherapy and onabotulinumtoxinA trials demonstrates the spectrum of treatments available for bladder symptoms when they persist after prolapse management [5, 6, 7]. Patients who have both prolapse and persistent overactive bladder may benefit from a staged approach: address the prolapse first, reassess bladder symptoms, and treat residual urgency incontinence with the appropriate medical or procedural therapy.
Uterine preservation versus hysterectomy
Women who wish to preserve their uterus — either for fertility or personal preference — now have surgical options that do not require hysterectomy. Uterine-sparing prolapse repairs (uterosacral ligament suspension, sacrospinous hysteropexy, Manchester procedure, and laparoscopic sacrohysteropexy) have growing evidence behind them and are increasingly offered at specialized centers.
For women who are done with childbearing and open to hysterectomy, combining hysterectomy with vault suspension at the time of prolapse repair reduces the risk of the uterus descending again as a separate prolapse recurrence. This is a nuanced surgical planning decision that depends on your anatomy, the type of prolapse, and your goals.
Questions to ask your doctor
- What stage is my prolapse, and which compartments are affected — bladder, uterus, rectum, or vaginal vault?
- Am I a candidate for a pessary fitting, and what types would work for my anatomy?
- If I try a pessary and decide later to have surgery, does that affect my surgical options in any way?
- Do I have occult stress incontinence that a pessary or surgery might unmask?
- If I want surgery, what is your preferred approach for my type of prolapse, and what are your recurrence rates?
- Would I be a candidate for uterine-sparing surgery if I want to preserve my uterus?
- What can I do to reduce the risk of prolapse worsening or recurring — weight loss, pelvic floor exercises, treating chronic cough?
The bottom line
Surgery and pessary are both effective treatments for pelvic organ prolapse, and neither is automatically superior. A pessary provides ongoing symptom relief without surgery, is reversible, and suits women who want to avoid an operation or are not yet ready to decide. Surgery provides a structural repair that is most effective in women who want a more permanent solution and are healthy enough to tolerate the procedure. Recurrence after surgery is common enough that pessary is a reasonable long-term strategy even for women who ultimately choose surgical repair. The overlap between prolapse and incontinence means both conditions should be evaluated together, with a specialist experienced in female pelvic floor medicine.
Research informing this article
Peer-reviewed research from the following specialists listed on Convene informs this explainer. They did not write or review the article; their published work is cited throughout.
- Howard Goldman
Professor, Cleveland Clinic Lerner College of Medicine; Vice Chairman for Clinical Affairs, Glickman Urological & Kidney Institute
Cleveland Clinic
- Victor Nitti
Professor of Urology and Obstetrics and Gynecology, Chief of Urogynecology and Reconstructive Pelvic Surgery, Fellowship Director, Shlomo Raz Chair in Urology
Santa Monica UCLA Medical Center and Orthopaedic Hospital
- Sandip Vasavada
Urological Director, Center for Female Pelvic Medicine and Reconstructive Surgery, Cleveland Clinic, Glickman Urological Institute
Cleveland Clinic (9500 Euclid Avenue, Cleveland, OH 44195)
Sources
- 1.6th International Consultation on Incontinence. Recommendations of the International Scientific Committee: EVALUATION AND TREATMENT OF URINARY INCONTINENCE, PELVIC ORGAN PROLAPSE AND FAECAL INCONTINENCE — Neurourology and Urodynamics, 2018. DOI
- 2.The International Continence Society (ICS) report on the terminology for adult male lower urinary tract and pelvic floor symptoms and dysfunction — Neurourology and Urodynamics, 2019. DOI
- 3.An International Urogynecological Association (IUGA) / International Continence Society (ICS) joint report on the terminology for female pelvic organ prolapse (POP) — International Urogynecology Journal, 2016. DOI
- 4.Surgical Treatment of Female Stress Urinary Incontinence: AUA/SUFU Guideline — The Journal of Urology, 2017. DOI
- 5.Fourth international consultation on incontinence recommendations of the international scientific committee: Evaluation and treatment of urinary incontinence, pelvic organ prolapse, and fecal incontinence — Neurourology and Urodynamics, 2009. DOI
- 6.OnabotulinumtoxinA for the Treatment of Patients with Overactive Bladder and Urinary Incontinence: Results of a Phase 3, Randomized, Placebo Controlled Trial — The Journal of Urology, 2012. DOI
- 7.Efficacy and Safety of OnabotulinumtoxinA for Idiopathic Overactive Bladder: A Double-Blind, Placebo Controlled, Randomized, Dose Ranging Trial — The Journal of Urology, 2010. DOI
- 8.Diagnosis and Treatment of Overactive Bladder (Non-Neurogenic) in Adults: AUA/SUFU Guideline Amendment — The Journal of Urology, 2015. DOI
- 9.Diagnosis and Treatment of Overactive Bladder (Non-Neurogenic) in Adults: AUA/SUFU Guideline Amendment 2019 — The Journal of Urology, 2019. DOI
- 10.Transobturator Tape Compared With Tension-Free Vaginal Tape for the Treatment of Stress Urinary Incontinence — Obstetrics and Gynecology, 2008. DOI
Related articles
urology
Active surveillance vs surgery for low-risk prostate cancer
Comparing active surveillance and radical prostatectomy for low-risk prostate cancer: what major trials show about survival, side effects, and who each approach fits.
urology
How to Prevent Kidney Stones From Coming Back After Your First Episode
Evidence-based guide to kidney stone recurrence prevention — the metabolic workup, fluid targets, dietary changes, and medications that urologists recommend after a first stone.
urology
Kidney Mass Workup: What to Expect After an Incidental Finding and When Surgery Is Needed
What happens after a kidney mass is found on imaging — the diagnostic workup, RENAL score, biopsy role, surveillance vs. surgery vs. ablation, and the AUA guideline recommendations.